Systems immunology meets clinical translation: Multi-omic approaches to predict therapy response in cancer and autoimmune disease

Системная иммунология и клиническая трансляция: мультиомные подходы к прогнозированию ответа на терапию при онкологических и аутоиммунных заболеваниях
Praveen Kumar Chandra Sekar, Ramakrishnan Veerabathiran
2025-12-23

multi-omic integrationpersonalized immunotherapyspatial biologysystems immunologytherapy response prediction
The immune system is governed by complex, interconnected molecular and cellular networks that shape disease risk and treatment outcome. Conventional biomarkers in cancer and autoimmune disease often rely on single parameters and fail to capture immune heterogeneity, resulting in variable therapeutic responses. Systems immunology integrates genomics, transcriptomics, epigenomics, proteomics, metabolomics, and microbiome profiling to generate holistic models of immune function. This review examines how multi-omic integration improves the prediction of therapy response across solid and hematologic malignancies and autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and inflammatory bowel disease. Advances in machine learning, network modeling, and spatial biology are discussed as critical enablers of immune stratification and biomarker discovery. Although integrated approaches outperform single-omics predictors, challenges remain in clinical validation, interpretability, and cost-effectiveness. We propose a translational framework in which targeted multi-omic panels and computational modeling guide personalized immunotherapy, shifting immune-based treatment from empirical intervention toward predictive, systems-driven precision medicine.
1
Clinical translation remains limited by challenges in validation, interpretability, and cost-effectiveness; targeted multi-omic panels are proposed to support predictive precision immunotherapy.
2
Conventional single-parameter biomarkers inadequately capture immune heterogeneity, contributing to variable treatment responses in cancer and autoimmune disease.
3
Integrating genomics, transcriptomics, epigenomics, proteomics, metabolomics, and microbiome data enables more holistic modeling of immune function.
4
Machine learning, network modeling, and spatial biology support immune stratification and biomarker discovery in clinically relevant settings.
5
Multi-omic approaches outperform single-omics predictors for therapy-response prediction across cancers and autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and inflammatory bowel disease.

Immune responses to therapy in cancer and autoimmune diseases

Prediction of therapy response and immune stratification using integrated multi-omic molecular and cellular profiles

Publication Details
Publication Date
2025-12-23
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Praveen Kumar Chandra Sekar
Ramakrishnan Veerabathiran
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%